Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

iRhythm Holdings Inc. (IRTC)

NASDAQ: IRTC · Surgical & Medical Instruments & Apparatus · San Francisco, CA

Our rating: Positive

Call changed from Neutral to Positive at $93.56, moderate conviction, November 12, 2026.

Breaks if: The Positive view breaks if revenue growth decelerates below 15% on a trailing-twelve-month basis at any of the next three quarterly prints, or if free cash flow turns negative for two consecutive quarters — either outcome would indicate the franchise is losing volume or pricing momentum faster than the current trajectory implies and would remove the core justification for holding a premium multiple on a still-loss-making business.

Key figures

Market value$3.2B
Revenue, last 12 months$854M
Net income, last 12 months−$39M
Free cash flow, last 12 months$7M
Price to earningsn/a
Free cash flow yield0.2%
Dividend yield0.0%
Operating margin−5.7%
Return on equity−25.8%
Beta to the S&P 5000.76
Volatility, annualized53.2%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$222M14.9%$-0.90−$12M
June 30, 2026$224M20.1%$-0.01$38M
March 31, 2026$199M25.7%$-0.43−$33M
December 31, 2025$209M27.1%$0.18$14M
September 30, 2025$193M30.7%$-0.16$20M
June 30, 2025$187M26.1%$-0.44$17M
March 31, 2025$159M20.3%$-0.97−$17M
December 31, 2024$164M24.0%$-0.04$12M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

15 ledger entries and 56 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.